🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David Roife

ORCID: 0000-0001-9052-2248

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes”.

CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes

JCO Precision Oncology(2020)10.1200/po.19.00330

N/A

0DataRank · unranked

17 citations

Johannes F. Fahrmann, Mayrim V. Rios Perez, Jody V. Vykoukal, Ehsan Irajizad, S. C. Tripathi +25 more

CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop

Molecular Metabolism(2021)10.1016/j.molmet.2021.101426

N/A

0DataRank · unranked

20 citations

Michela Capello, Mayrim V. Rios Perez, Jody V. Vykoukal, David Roife, Ya’an Kang +17 more

Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway

Cell Death and Disease(2021)10.1038/s41419-021-03970-8

N/A

0DataRank · unranked

11 citations

Jithesh J. Augustine, Ya’an Kang, David Roife, Xinqun Li, Jenying Deng +7 more